Company: KG
Filing Date: 2025-03-10
Form Type: S-4
Source: 0001104659-25-021993
Chunk: 284

Company: Kestrel Group Ltd
Filing Date: 2025-03-10
Form: S-4
Chunk 284
---
 of whether the employment termination is in connection with the mergers or a change in control, out of an abundance of caution we are describing them in this prospectus/proxy statement. (2) The amounts in this column represent the equity awards that will continue to vest until March 14, 2026, assuming the termination of employment of Mr. Haveron or Metz without cause under the terms of the restricted share award agreements dated as of March 17, 2023 and March 14, 2024. Although these amounts are payable irrespective of whether the employment termination is in connection with the mergers or a change in control, out of an abundance of caution we are describing them in this prospectus/proxy statement. The amounts in this column do not include equity awards that will continue to remain subject to performance vesting conditions assuming the termination of employment of Mr. Haveron or Metz without cause under the terms of the restricted share award agreements dated as of March 17, 2023 and March 7, 2024. (3) The amounts in this column represent the approximate value of continued payment of certain employee benefits including medical insurance ($47,424 and $47,424), executive life insurance ($22,766 and $2,263), supplemental allowance ($56,909 and $37,939) and executive physical ($6,619 and $18,000) for Messrs. Haveron and Metz, respectively, until May 1, 2028, assuming the termination of employment of Mr. Haveron or Metz without cause under the terms of the employment agreements as of March 3, 2025. Although these amounts are payable irrespective of whether the employment termination is in

185

TABLE OF CONTENTS

connection with the mergers or a change in control, out of an abundance of caution we are describing them in this prospectus/proxy statement.

(4)

The amounts in this column represent the value of accrued vacation assuming the termination of employment of Mr. Haveron or Metz without cause under the terms of the employment agreements as of March 3, 2025. Although these amounts are payable irrespective of whether the employment termination is in connection with the mergers or a change in control, out of an abundance of caution we are describing them in this prospectus/proxy statement.

#### Merger-Related Compensation Proposal
Pursuant to the Dodd-Frank Act and Rule 14a-21(c) of the Exchange Act, Maiden is seeking a